tetra(4-N-methylpyridyl)porphine

structure in first source

Also Known As:

5,10,15,20- tetra- (N- methyl- 4- pyridyl)porphyrin; 5,10,15,20- tetrakis(1- methyl- 4- pyridyl)- 21H,23H- porphine; 5,10,15,20- tetrakis(N- methylpyridinium- 4- yl)- 21H,23H- porphyrin; 5,10,15,20- tetrakis(methyl- 4- pyridyl)- 21H,23H- porphine- tetra- p- tosylate salt; TMPP cpd; TMPYP; TMPyP4; TN-Et-PyP; alpha,beta,gamma,delta- tetrakis(4- N- methylpyridyl)porphine; meso-tetra(4-N-methylpyridyl)porphine; meso-tetra(4-N-methylpyridyl)porphine tetraperchlorate; meso-tetra(N-methyl-4-pyridyl)porphine tetratosylate; meso- tetrakis(2- N- methylpyridyl)porphine; mesotetra(4-N-methylpyridyl)porphine; tetra(4-N-methylpyridyl)porphine tetraiodide; tetra(4-N-methylpyridyl)porphine tetraperchlorate; tetra(4-N-methylpyridyl)porphine tosylate (1:4); tetra-Py-Me; tetrakis(N- ethylpyridinium- 4- yl)porphyrin; tetrakis(N- ethylpyridinium- 4- yl)porphyrin tetratosylate; tetrakis(N-methyl-4-pyridino)porphine; (4,4',4'',4'''- (21H,23H)- porphine- 5,10,15,20- tetrayl)tetrakis(1-methylpyridinium)

Pharmalogical Action Categories:

D000890 - Anti-Infective Agents
D004791 - Enzyme Inhibitors
D017319 - Photosensitizing Agents
D020533 - Angiogenesis Inhibitors

Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Azoles: 2199
    - Pyrroles: 381
      - Tetrapyrroles: 71
        Porphyrins: 3373
        tetra(4-N-methylpyridyl)porphine: 80
- Fused-Ring Heterocyclic Compounds
  - 4 or More Rings Heterocyclic Compounds
    - Tetrapyrroles: 71
      - Porphyrins: 3373
        tetra(4-N-methylpyridyl)porphine: 80
Polycyclic Compounds: 7
- Macrocyclic Compounds: 16
  - Tetrapyrroles: 71
    - Porphyrins: 3373
      - tetra(4-N-methylpyridyl)porphine: 80
Biological Factors: 2560
- Biological Pigments: 1
  - Porphyrins: 3373
    - tetra(4-N-methylpyridyl)porphine: 80

Wen-Ming Xiong Selected Research

Wen-Ming Xiong Research Topics

Disease

Drug/Important Bio-Agent (IBA)